Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Sayler, E
141  Ergebnisse:
Personensuche X
?
1

SU‐E‐T‐191: Commissioning and Dosimetric Characteristics of..:

Sayler, E ; Charpentier, P ; Micaily, B..
Medical Physics.  42 (2015)  6Part14 - p. 3375-3375 , 2015
Link: https://doi.org/10.1118/..
 
?
2

SU-E-J-44: A Novel Approach to Quantify Patient Setup and T..:

Li, S ; Charpentier, P ; Sayler, E...
Medical Physics.  42 (2015)  6 - p. 3273-3273 , 2015
Link: https://doi.org/10.1118/..
 
?
3

SU‐C‐BRD‐02: A Team Focused Clinical Implementation and Fai..:

Sayler, E ; Harrison, A ; Eldredge‐Hindy, H...
Medical Physics.  41 (2014)  6Part2 - p. 95-95 , 2014
Link: https://doi.org/10.1118/..
 
?
4

SU-E-T-131: Effect of Scanning Speed On MV and FFF Dosimetr..:

Sayler, E ; Gardner, S ; Buzurovic, I.
Medical Physics.  40 (2013)  6Part12 - p. 234-234 , 2013
Link: https://doi.org/10.1118/..
 
?
5

The calcium channel blocker nisoldipine minimizes the relea..:

Sayler, E. ; Shedlofsky, S. I. ; Swim, A. T...
Transplant International.  5 (1992)  - p. S398-S402 , 1992
Link: https://doi.org/10.1111/..
 
?
6

Assessments of Local Bronchopulmonary Functions and Nodule ..:

Li, S. ; Miyamoto, C. ; Micaily, B....
International Journal of Radiation Oncology*Biology*Physics.  93 (2015)  3 - p. E425 , 2015
Link: https://doi.org/10.1016/..
 
?
7

The influence of pharmacotherapy on selfdirected and extern..:

Beasley, C.M. ; Sayler, M.E. ; Kiesler, G.M....
Schizophrenia Research.  29 (1998)  1-2 - p. 28 , 1998
Link: https://doi.org/10.1016/..
 
?
8

Fluoxetine and suicide: An updated meta-analysis of control..:

Wernicke, J.F. ; Sayler, M.E. ; Beasley Jr., C.M.
Biological Psychiatry.  42 (1997)  1 - p. 246S , 1997
Link: https://doi.org/10.1016/..
 
?
9

P.1.107 Influence of concomitant medications on fluoxetine ..:

Wernicke, J.F. ; Sayler, M.E. ; Koke, S.C..
European Neuropsychopharmacology.  7 (1997)  - p. S169 , 1997
Link: https://doi.org/10.1016/..
 
?
10

The efficacy of fluoxetine in the treatment of depression w..:

Plewes, J.M. ; Vieira-Brisson, T. ; Sayler, M.E....
Biological Psychiatry.  42 (1997)  1 - p. 246S-247S , 1997
Link: https://doi.org/10.1016/..
 
?
11

P.1.108 Adverse events and treatment discontinuations in fl..:

Plewes, J.M. ; Koke, S.C. ; Sayler, M.E.
European Neuropsychopharmacology.  7 (1997)  - p. S169 , 1997
Link: https://doi.org/10.1016/..
 
?
12

Does fluoxetine cause activation, sedation, both, or neithe..:

Wernicke, J.F. ; Sayler, M.E. ; Koke, S.C..
Biological Psychiatry.  42 (1997)  1 - p. 246S , 1997
Link: https://doi.org/10.1016/..
 
?
13

The sefety of fluoxetine in the treatment of depression wit..:

Plewes, J.M. ; Vieira-Brisson, T. ; Sayler, M.E....
Biological Psychiatry.  42 (1997)  1 - p. 246S , 1997
Link: https://doi.org/10.1016/..
 
?
14

The course of psychomotor agitation during pharmacotherapy ..:

Tollefson, G.D. ; Sayler, M.E.
Biological Psychiatry.  42 (1997)  1 - p. 246S , 1997
Link: https://doi.org/10.1016/..
 
?
15

Severity of depression and response to fluoxetine:

Pande, A. C. ; Sayler, M. E.
International Clinical Psychopharmacology.  8 (1993)  4 - p. 243-246 , 1993
Link: https://doi.org/10.1097/..
 
1-15